Pretreatment levels of urinary deoxypyridinoline as a potential marker in patients with prostate cancer with or without bone metastasis - Concepedia

Concepedia

Publication | Closed Access

Pretreatment levels of urinary deoxypyridinoline as a potential marker in patients with prostate cancer with or without bone metastasis

18

Citations

9

References

2001

Year

L.F.A. Wymenga, Klaas H. Groenier, Jaap‐Peter Schuurman, J.H.B. Boomsma, R. Oude Elferink, H.J.A. Mensink

British Journal of Urology

Abstract

Serum ALP or urinary DPD are the best predictors of bone metastasis in patients with prostate cancer; further studies with more patients are required.

References

	Year	Citations

Page 1